[ET Net News Agency, 29 September 2026] KEYMED BIO-B (02162) rose 9.6% to HK$80.2.
It hits an intra-day high of HK$80.5, breaking above the 50-D SMA of HK$77.758, and an intra-day low of HK$75. The total shares traded was 2.17 million, with a value of HK$169.29m. The active buy/sell ratio is 55:45, with net buying turnover of HK$17.04m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$11.19m, with volume weighted average price of HK$78.173. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$8.17m, with volume weighted average price of HK$78.22.
Basic Information| Nominal | 80.200 | % Chg | +9.64% |
| High | 80.500 | Low | 75.000 |
| Shares Tr | 2.17m | Turnover | 169.29m |
| 10-D SMA | 75.755 | %H.V | 54.189 |
| 20-D SMA | 76.288 | VWAP | 78.083 |
| 50-D SMA | 77.758 | RSI14 | 56.321 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 55:45, with net buying turnover of HK$17.04m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| KEYMED BIO-B (02162) | 80.20 | +9.64 |
| GENSCRIPT BIO (01548) | 40.60 | -3.33 |
| INNOVENT BIO (01801) | 96.35 | +0.21 |
| XTALPI (02228) | 7.75 | +1.37 |
| WUXI XDC (02268) | 77.60 | -2.08 |
| WUXI BIO (02269) | 53.05 | -0.66 |
| WUXI APPTEC (02359) | 207.20 | +0.58 |
| BEONE MEDICINES (06160) | 219.00 | +0.64 |
| AKESO (09926) | 106.10 | +15.33 |
| REMEGEN (09995) | 74.60 | +4.78 |
(ed)
Nominal 
